Singapore markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
292.41+7.67 (+2.69%)
At close: 04:00PM EDT
291.91 -0.50 (-0.17%)
Pre-market: 06:27AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close284.74
Bid0.00 x 1100
Ask0.00 x 800
Day's range286.02 - 293.83
52-week range176.36 - 305.95
Avg. volume1,381,998
Market cap74.991B
Beta (5Y monthly)0.45
PE ratio (TTM)23.91
EPS (TTM)12.23
Earnings date31 Oct 2022 - 04 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est310.54
  • Motley Fool

    3 Stocks to Buy if You're Afraid to Buy Stocks

    Concerns are mounting that a full-blown recession could be on the way. Here are three stocks to buy if you're afraid of buying stocks. The stock market's huge downturn so far this year hasn't impacted Vertex Pharmaceuticals (NASDAQ: VRTX) in the least.

  • Zacks

    Vertex (VRTX), CRISPR to Seek FDA Nod for Hemoglobinopathy Therapy

    Vertex (VRTX) and partner CRISPR intend to start a rolling BLA submission with the FDA for their gene therapy in thalassemia and sickle cell disease indications by November 2022.

  • Motley Fool

    3 Biotech Stocks to Buy and Hold for the Next 10 Years

    Several biotech stocks have outperformed the struggling market this year. This list includes Vertex Pharmaceuticals (NASDAQ: VRTX), Exelixis (NASDAQ: EXEL), and Amgen (NASDAQ: AMGN). Let's consider why these three biotechs are solid buys for the next decade.